We are pleased to announce that Istituto Clinico Humanitas Mirasole S.p.A. has joined Hemera’s shareholding structure, acquiring a 1.5% stake in the company.
Humanitas is a highly specialized teaching and research hospital, accredited by the Italian National Health Service as an IRCCS (Scientific Institute for Research, Hospitalization and Healthcare), and is recognized as one of the most technologically advanced clinical centers in Europe.
Already a clinical partner of Hemera in the ongoing observational study, Humanitas represents a strategic reference point for exploring new clinical applications.
Its entry further strengthens our development plan and confirms the importance of collaboration between research, clinical expertise, and enterprise in advancing the field of regenerative medicine.